GABA_A Receptor Antagonism Ameliorates Behavioral and Synaptic Impairments Associated with MeCP2 OverexpressionNA, Elisa S; MORRIS, Michael J; NELSON, Erika D et al.Neuropsychopharmacology (New York, NY). 2014, Vol 39, Num 8, pp 1946-1954, issn 0893-133X, 9 p.Article

Role of DNA methylation and the DNA methyltransferases in learning and memoryMORRIS, Michael J; MONTEGGIA, Lisa M.Dialogues in clinical neuroscience. 2014, Vol 16, Num 3, pp 359-371, issn 1294-8322, 13 p.Article

Androgen Deprivation and Thromboembolic Events in Men with Prostate CancerEHDAIE, Behfar; ATORIA, Coral L; GUPTA, Amit et al.Cancer. 2012, Vol 118, Num 13, pp 3397-3406, issn 0008-543X, 10 p.Article

Germline BRCA mutation does not prevent response to taxane―based therapy for the treatment of castration―resistant prostate cancerGALLAGHER, David J; CRONIN, Angel M; MILOWSKY, Matthew I et al.BJU international (Papier). 2012, Vol 109, Num 5, pp 713-719, issn 1464-4096, 7 p.Article

Phase I Dose-Escalation Study of the Novel Antiandrogen BMS-641988 in Patients with Castration-Resistant Prostate CancerRATHKOPF, Dana; LIU, Glenn; FUNG, Nga Kit Eliza et al.Clinical cancer research (Print). 2011, Vol 17, Num 4, pp 880-887, issn 1078-0432, 8 p.Article

Transitioning the Respiratory Therapy Workforce for 2015 and BeyondBARNES, Thomas A; KACMAREK, Robert M; KAGELER, Woody V et al.Respiratory care. 2011, Vol 56, Num 5, pp 681-690, issn 0020-1324, 10 p.Article

High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinomaMORRIS, Michael J; SMALETZ, Oren; ZHU, Andrew et al.Cancer. 2004, Vol 100, Num 9, pp 1868-1875, issn 0008-543X, 8 p.Article

Bone Scan Index: A Quantitative Treatment Response Biomarker for Castration-Resistant Metastatic Prostate CancerDENNIS, Elizabeth R; XIAOYU JIA; MEZHERITSKIY, Irina S et al.Journal of clinical oncology. 2012, Vol 30, Num 5, pp 519-524, issn 0732-183X, 6 p.Article

Relapsing Polychondritis in the Department of Defense Population and Review of the LiteratureMATHEW, Stephanie D; BATTAFARANO, Daniel F; MORRIS, Michael J et al.Seminars in arthritis and rheumatism. 2012, Vol 42, Num 1, pp 70-83, issn 0049-0172, 14 p.Article

Perioperative Complications of Simultaneous versus Staged Unicompartmental Knee ArthroplastyBEREND, Keith R; MORRIS, Michael J; SKEELS, Michael D et al.Clinical orthopaedics and related research. 2011, Vol 469, Num 1, pp 168-173, issn 0009-921X, 6 p.Article

Respiratory dialysis: Reduction in dependence on mechanical ventilation by venovenous extracorporeal CO₂ removalBATCHINSKY, Andriy I; JORDAN, Bryan S; REGN, Dara et al.Critical care medicine. 2011, Vol 39, Num 6, pp 1382-1387, issn 0090-3493, 6 p.Article

Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate CancerDANILA, Daniel C; MORRIS, Michael J; MOLINA, Arturo et al.Journal of clinical oncology. 2010, Vol 28, Num 9, pp 1496-1501, issn 0732-183X, 6 p.Article

Mineralocorticoid Receptor Antagonism Prevents Hedonic Deficits Induced by a Chronic Sodium AppetiteMORRIS, Michael J; NA, Elisa S; JOHNSON, Alan Kim et al.Behavioral neuroscience. 2010, Vol 124, Num 2, pp 211-224, issn 0735-7044, 14 p.Article

A 49-Year-Old Man With Concurrent Diagnoses of Lung Cancer, Sarcoidosis, and Multiple Regions of Adenopathy on Positron Emission TomographyMCNEILL, Matthew; ZANDERS, Thomas B; MORRIS, Michael J et al.Chest (American College of Chest Physicians). 2009, Vol 135, Num 2, pp 546-549, issn 0012-3692, 4 p.Article

Community meetings for emergency research community consultationLONGFIELD, Jenice N; MORRIS, Michael J; MORAN, Kimberly A et al.Critical care medicine. 2008, Vol 36, Num 3, pp 731-736, issn 0090-3493, 6 p.Article

Effects of serotonin 5-HT1A agonist in advanced Parkinson's diseaseBARA-JIMENEZ, William; BIBBIANI, Francesco; MORRIS, Michael J et al.Movement disorders. 2005, Vol 20, Num 8, pp 932-936, issn 0885-3185, 5 p.Article

Study of Active Duty Military for Pulmonary Disease Related to Environmental Deployment Exposures (STAMPEDE)MORRIS, Michael J; DODSON, Darrel W; LUCERO, Pedro F et al.American journal of respiratory and critical care medicine. 2014, Vol 190, Num 1, pp 77-84, issn 1073-449X, 8 p.Article

A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumorsIYER, Gopa; MORRIS, Michael J; HELLER, Glenn et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 4, pp 1089-1097, issn 0344-5704, 9 p.Article

Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trialANTONARAKIS, Emmanuel S; CARDUCCI, Michael A; EISENBERGER, Mario A et al.Cancer chemotherapy and pharmacology. 2012, Vol 69, Num 3, pp 763-771, issn 0344-5704, 9 p.Article

Inspiratory Flow-Volume Curve Evaluation for Detecting Upper Airway DiseaseSTERNER, James B; MORRIS, Michael J; SILL, Joshua M et al.Respiratory care. 2009, Vol 54, Num 4, pp 461-466, issn 0020-1324, 6 p.Article

Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate CancerYU, Evan Y; WILDING, George; TRUDEL, Géralyn C et al.Clinical cancer research (Print). 2009, Vol 15, Num 23, pp 7421-7428, issn 1078-0432, 8 p.Article

Efficacy and safety of single-agent pertuzumab (rhuMAb 2C4), a human epidermal growth factor receptor dimerization inhibitor, in castration-resistant prostate cancer after progression from taxane-based therapyAGUS, David B; SWEENEY, Christopher J; ALLISON, David E et al.Journal of clinical oncology. 2007, Vol 25, Num 6, pp 675-681, issn 0732-183X, 7 p.Article

Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancerSOLIT, David B; IVY, S. Percy; LARSON, Steven et al.Clinical cancer research. 2007, Vol 13, Num 6, pp 1775-1782, issn 1078-0432, 8 p.Article

Optimizing targeted therapy and developing novel outcome measures for patients with advanced prostate cancer at Memorial Sloan-Kettering Cancer CenterMORRIS, Michael J; SCHER, Howard I.Critical reviews in oncology/hematology. 2003, Vol 46, pp S21-S31, issn 1040-8428, SUPConference Paper

Fluorinated deoxyglucose positron emission tomography imaging in progressive metastatic prostate cancerMORRIS, Michael J; AKHURST, Timothy; OSMAN, Iman et al.Urology (Ridgewood, NJ). 2002, Vol 59, Num 6, pp 913-918, issn 0090-4295Article